Sponsor:
Pfizer
Code:
NCT07932925
Conditions
Urinary Incontinence, Stress
Overweight and/or Obesity
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Berobenatide
Placebo
Brief summary:
Conditions
Urinary Incontinence, Stress
Overweight and/or Obesity
Study ID
NCT07932925
Start date
Nov 17, 2026
Status verified date
Nov, 2026
Completion date
Dec 1, 2028
Anticipated
Primary completion date
Oct 13, 2028
Anticipated
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
900 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
active comparator: Arm 1
placebo comparator: Arm 2
Interventions
Berobenatide
Placebo
Primary outcome measure
Central contacts
Locations
Madison Imaging Center
Recruiting
Citrus Heights, California, United States, 95610
Northern California Research
Recruiting
Sacramento, California, United States, 95821
Hawthorne Health - Boynton Beach, FL
Recruiting
Boynton Beach, Florida, United States, 33436
New Age Medical Research Corporation
Recruiting
Miami, Florida, United States, 33186
Hawthorne Health - Horsham, PA
Recruiting
Horsham, Pennsylvania, United States, 19044
Clinical Trial Network
Recruiting
Houston, Texas, United States, 77074
Sponsor
Pfizer
Last update posted
Nov 19, 2026
Last verified
Nov, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-20. This information was provided to ClinicalTrials.gov by Pfizer on 2026-11-19. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.